Evidence map›Paper›PMID 36185173›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2022

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs.

Marika T Leving, Job F M van Boven, Sinthia Z Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Marina García Pardo, Asparuh Gardev and 15 more

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Determinants of Inhaler Choice at Hospital Discharge.Medical sciences (Basel, Switzerland) · 2026
    Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Marika T LevingGeneral Practitioners Research Institute, Groningen, the Netherlands.ORCID 0000-0002-2732-4406
Job F M van BovenUniversity Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, the Netherlands.ORCID 0000-0003-2368-2262
Sinthia Z Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.ORCID 0000-0001-5077-8329
Joyce van CootenGeneral Practitioners Research Institute, Groningen, the Netherlands.
Jaime Correia de SousaLife and Health Sciences Research Institute (ICVS), PT Government Associate Laboratory, School of Medicine, University of Minho, Braga, Portugal.ORCID 0000-0001-6459-7908
Biljana CvetkovskiWoolcock Institute of Medical Research, University of Sydney, Sydney, Australia.
Richard DekhuijzenRadboud University Medical Centre, Nijmegen, Netherlands.
Lars DijkGeneral Practitioners Research Institute, Groningen, the Netherlands.ORCID 0000-0002-9544-1487
Marina García PardoPrimary Care Respiratory Research Unit, Instituto De Investigación Sanitaria De Baleares (IdISBa), Palma de Mallorca, Spain.
Asparuh GardevBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.
Radosław GawlikDepartment of Internal Medicine, Allergology, Clinical Immunology, Medical University of Silesia, Katowice, Poland.
Iris van der HamGeneral Practitioners Research Institute, Groningen, the Netherlands.
Elisabeth Sophia Hartgers-GubbelsBoehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany.ORCID 0000-0002-5120-7621
Ymke JanseGeneral Practitioners Research Institute, Groningen, the Netherlands.
Federico LavoriniDepartment of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.ORCID 0000-0002-3293-2123
Tiago MaricotoFaculty of Health Sciences, University of Beira Interior, Covilha, Portugal.
Jiska MeijerGeneral Practitioners Research Institute, Groningen, the Netherlands.
Boyd MetzGeneral Practitioners Research Institute, Groningen, the Netherlands.
David B PriceCentre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-9728-9992
Miguel Roman-RodríguezPrimary Care Respiratory Research Unit, Instituto De Investigación Sanitaria De Baleares (IdISBa), Palma de Mallorca, Spain.ORCID 0000-0001-9155-1411
Kirsten SchuttelGeneral Practitioners Research Institute, Groningen, the Netherlands.
Nilouq StokerGeneral Practitioners Research Institute, Groningen, the Netherlands.
Ioanna TsiligianniDepartment of Social Medicine, Health Planning Unit, Faculty of Medicine, University of Crete, Rethymno, Greece.
Omar S UsmaniAirway Disease, National Heart and Lung Institute (NHLI), Imperial College London and Royal Brompton Hospital, London, UK.ORCID 0000-0002-4367-254X
Janwillem H KocksGeneral Practitioners Research Institute, Groningen, the Netherlands.ORCID 0000-0002-2760-0693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To assess the relationship between suboptimal Peak Inspiratory Flow (sPIF), inhalation technique errors, and non-adherence, with Healthcare Resource Utilisation (HCRU) in Chronic Obstructive Pulmonary Disease (COPD) patients receiving maintenance therapy via a Dry Powder Inhaler (DPI). Patients and methods: The cross-sectional, multi-country PIFotal study included 1434 COPD patients (≥40 years) using a DPI for maintenance therapy. PIF was measured with the In-Check DIAL G16, and sPIF was defined as a typical PIF lower than required for the device. Inhalation technique was assessed by standardised evaluation of video recordings and grouped into 10 steps. Patients completed the "Test of Adherence to Inhalers" questionnaire. HCRU was operationalised as COPD-related costs for primary healthcare, secondary healthcare, medication, and total COPD-related costs in a 1-year period. Results: Participants with sPIF had higher medication costs compared with those with optimal PIF (cost ratio [CR]: 1.07, 95% CI [1.01, 1.14]). Multiple inhalation technique errors were associated with increased HCRU. Specifically, "insufficient inspiratory effort" with higher secondary healthcare costs (CR: 2.20, 95% CI [1.37, 3.54]) and higher total COPD-related costs (CR: 1.16, 95% CI 1.03-1.31). "no breath-hold following the inhalation manoeuvre (<6 s)" with higher medication costs (CR: 1.08, 95% CI [1.02, 1.15]) and total COPD-related costs (CR 1.17, 95% CI [1.07, 1.28]), and "not breathing out calmly after inhalation" with higher medication costs (CR: 1.19, 95% CI [1.04, 1.37]). Non-adherence was not significantly associated with HCRU. Conclusion: sPIF and inhalation technique errors were associated with higher COPD-related healthcare utilisation and costs in COPD patients on DPI maintenance therapy.

Indexed as

Pulmonary Disease, Chronic ObstructiveAdministration, InhalationCross-Sectional StudiesDry Powder InhalersHealth Care CostsHumanschronic obstructive pulmonary diseasecost analysisDry Powder Inhalerhealthcare resource utilisationhealth economics

Identifiers

PMID36185173
PMCPMC9521797

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.